Terra Innovatum Global N.V. (NKLR) Q1 2026 earnings summary

Executive summary

• Focused on developing the SOLO micro-modular nuclear reactor, targeting commercial deployment by 2028, with no revenue generated to date as activities remain in R&D and regulatory engagement phases.

• Completed conceptual and detailed design phases, initiated pre-application engagement with the U.S. NRC, and established a supply chain strategy for future deployment.

• Operates as a single reportable segment, with all financial and operational results reviewed on a consolidated basis.

Financial highlights

• Net loss for Q1 2026 was $7,106,000, compared to $1,448,000 for Q1 2025, driven by higher operating expenses and fair value changes in contingent liabilities.

• Operating expenses rose to $6,634,000 from $1,449,000 year-over-year, mainly due to increased compensation, insurance, and technical consultancy.

• Cash and cash equivalents as of March 31, 2026, were $96,701,000, down from $102,882,000 at year-end 2025.

• Accumulated deficit reached $614,382,000 as of March 31, 2026.

• No revenue was generated in the period.

Outlook and guidance

• Anticipates continued increases in general and administrative expenses as a public company.

• Expects to require additional capital to fund operations and advance toward commercialization, with no meaningful revenue expected before 2028.

• Actively evaluating potential equity or debt financing, but no definitive agreements in place.